Zika News Update: FDA Approves Use Of Experimental Blood Test

zika-news-update-fda-approves-use-of-experimental-blood-test.jpg

The latest Zika news update comes from the Food and Drug Administration (FDA) in the US. The federal agency has approved the use of experimental blood test to screen traces of the virus in the donated blood. The blood test was manufactured by New Jersey-based Roche Holding AG. It screens the blood of donors for traces of the deadly virus in the countries and regions affected by its outbreak. The FDA has earlier issued guidelines to stop collecting donated blood samples from people residing in Zika-affected countries. Now, the agency has approved the use of the experimental blood test. However, the FDA is still urging Zika-affected regions to fulfill the demand of blood orders from the countries where the virus has not spread. If not, then the blood is required to be tested with an FDA-approved screening test.Like us on Facebook Zika Virus Could Just Be One Of The Several Viral Threats Transmitted By Mosquitoes The approval for using the experimental blood screening test would help ensure that there is no disruption of the blood supply to the countries affected by Zika virus, including the US territories experiencing active mosquito-born transmission of the virus. “The availability of an investigational test to screen donated blood for the Zika virus is an important step forward in maintaining the safety of the nation’s blood supply, especially for those US territories already experiencing active transmission,” said Dr Peter Mark of the FDA, in a press statement. Mark further said that since Zika is expected to hit other regions in the future as well, the blood collection establishments can continue to use the investigation test to screen blood samples, so that there is no disruption in the blood supply. It is estimated that the Zika virus has spread to almost 38 countries and territories across the world, mostly in the Carribean and Latin America. Another Zika news update came from FDA two weeks ago when they approved a three-in-one laboratory test for mosquito-borne diseases. The new test is expected to speed up the diagnosis of the virus. Photo Sources: Flickr, Pixabay